Pubblicazioni Scientifiche
Dermatologia22 set 2020
Tuscan Consensus on the diagnosis, treatment and follow up of adult atopic dermatitis
Atopic dermatitis (AD) is an inflammatory disease with a chronic-relapsing course that is intensely itchy.
22 set 2020
Technological advances for the detection of melanoma
Advances in diagnostic techniques
21 set 2020
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology
Pemphigus encompasses a group of life‐threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin.
14 set 2020
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
Vitiligo is a chronic autoimmune disease resulting in skin depigmentation and reduced quality of life.
14 set 2020
Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti–Interleukin 12/23p40 Antibody Ustekinumab
Is the risk of severe cardiovascular events increased after the initiation of treatment with the anti–interleukin 12/23p40 (IL-12/23p40) monoclonal antibody ustekinumab?
14 set 2020
A phase 2, open‐label study of single dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis
pharmacokinetics, safety and efficacy
30 ago 2020
Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides?
Results from the PROCLIPI international Study
30 ago 2020
Efficacy and safety of topical resorcinol 15% as long‐term treatment of mild‐to‐moderate hidradenitis suppurativa
a valid alternative to clindamycin in the panorama of antibiotic resistance
30 ago 2020
Primary Cutaneous B-Cell Lymphomas: An Update
Primary cutaneous B-cell lymphomas (PCBCLs) comprise a group of extranodal B-cell non-Hodgkin lymphomas B-cell derived, which primarily involve the skin without evidence of extracutaneous disease at the time of diagnosis.
03 ago 2020
Dermoscopy comparative approach for early diagnosis in familial melanoma: influence of MC1R genotype
MC1R polymorphisms interact with CDKN2A mutations modulating melanoma risk and contribute to a less suspicious clinical and dermoscopic appearance of melanomas.
03 ago 2020
Characteristics of non-melanoma skin cancer in children without identifiable risk factors
This paper is only available as a PDF. To read, Please Download here.
03 ago 2020
A Retrospective Multicenter Study of Fatal Pediatric Melanoma
Pediatric melanoma is rare and diagnostically challenging.
27 lug 2020
Pulsed-dye laser as an adjuvant treatment for discoid lupus erythematosus
A randomized, controlled trial
27 lug 2020
Lasers and intense pulsed light (IPL) association with cancerous lesions
The development and use of light and lasers for medical and cosmetic procedures has increased exponentially over the past decade.
27 lug 2020
Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea
Is mycophenolate a well-tolerated and beneficial treatment of morphea?
19 lug 2020
The importance of skin manifestations, serology and nailfold (video)capillaroscopy in morphea and systemic sclerosis
Current understanding and new insights
19 lug 2020
A 10‐year Review of Surgical Management of Dermatofibrosarcoma Protuberans
Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer.
19 lug 2020
Dermatoscopic features of thin versus thick nodular melanoma and predictors of nodular melanoma versus nodular non‐melanoma tumors
A multicentric collaborative study by the International Dermoscopy Society
15 lug 2020
Oral minoxidil treatment for hair loss: A review of efficacy and safety.
Although topical minoxidil is an effective treatment option for hair loss, many patients are poorly compliant due to the necessity to apply the medication twice a day, undesirable hair texture, and scalp irritation.
15 lug 2020
The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma.
The results of local-regional advanced melanoma (stage III) management are still not satisfactory.